This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H5N1 Matrix Protein 2 Ectodomain (M2e), N-GST and C-His
Product Overview
BioVenic's Recombinant Influenza A H5N1 Matrix Protein 2 Ectodomain (M2e), N-GST and C-His is a recombinant protein expressed from E.coli Expression System. Its predicted molecular weight is 31.1 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
The H5N1 M2e is the 23-residue extracellular tail of the Matrix 2 ion channel, specifically derived from Highly Pathogenic Avian Influenza (HPAI). While internal M2 residues facilitate proton transport, this N-terminal domain is exposed on the virion and infected cell surfaces. Despite the extreme virulence and HA mutations of H5N1, the M2e sequence is highly conserved. This makes it a premier candidate for cross-protective "universal" vaccines, inducing antibodies that provide protection via antibody-dependent cellular cytotoxicity (ADCC) against avian-origin threats.
Shipping and Storage
This product is shipped with gel ice bags. Avoid repeated freezing and thawing. Store for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.